# Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients

> **NCT06114953** · PHASE4 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 152 (estimated)

## Conditions studied

- Kidney Transplant Immunosuppression

## Interventions

- **DRUG:** Mizoribine
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT06114953
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06114953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06114953, "Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06114953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*